Ignite Creation Date:
2024-05-11 @ 8:31 AM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06400264
Status:
WITHDRAWN
Last Update Posted:
2024-05-06
First Post:
2024-05-03
Brief Title:
Testing Nivolumab and BMS-986016 Relatlimab as Potentially Targeting Treatment in Cancers That Are LAG-3 and Have Mismatch Repair Deficiency MATCH - Subprotocol Z1M
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Organization Data
Organization:
National Cancer Institute NCI
Class:
NIH
Study ID:
NCI-2024-01195
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
National Cancer Institute NCI
Lead Sponsor Class:
NIH
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None